Cargando…

Myoclonus-dystonia syndrome: case report

Myoclonus-dystonia syndrome (MDS) is a rare disease manifesting myoclonus as the only neurological symptom which may be accompanied by dystonia. It usually starts in the first or second decade of life. It has a benign course with spontaneous remissions but can cause functional disability in some pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Akarsu, Emel Oguz, Surmeli, Reyhan, Yalcin, Destina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175042/
https://www.ncbi.nlm.nih.gov/pubmed/28058330
http://dx.doi.org/10.14744/nci.2014.28247
_version_ 1782484582286753792
author Akarsu, Emel Oguz
Surmeli, Reyhan
Yalcin, Destina
author_facet Akarsu, Emel Oguz
Surmeli, Reyhan
Yalcin, Destina
author_sort Akarsu, Emel Oguz
collection PubMed
description Myoclonus-dystonia syndrome (MDS) is a rare disease manifesting myoclonus as the only neurological symptom which may be accompanied by dystonia. It usually starts in the first or second decade of life. It has a benign course with spontaneous remissions but can cause functional disability in some patients. In this paper, we report a patient diagnosed as probable MDS on the basis of clinical and electrophysiological features who showed marked improvement under levetiracetam treatment.
format Online
Article
Text
id pubmed-5175042
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-51750422017-01-05 Myoclonus-dystonia syndrome: case report Akarsu, Emel Oguz Surmeli, Reyhan Yalcin, Destina North Clin Istanb Case Report Myoclonus-dystonia syndrome (MDS) is a rare disease manifesting myoclonus as the only neurological symptom which may be accompanied by dystonia. It usually starts in the first or second decade of life. It has a benign course with spontaneous remissions but can cause functional disability in some patients. In this paper, we report a patient diagnosed as probable MDS on the basis of clinical and electrophysiological features who showed marked improvement under levetiracetam treatment. Kare Publishing 2015-01-24 /pmc/articles/PMC5175042/ /pubmed/28058330 http://dx.doi.org/10.14744/nci.2014.28247 Text en Copyright © Istanbul Northern Anatolian Association of Public Hospitals http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Case Report
Akarsu, Emel Oguz
Surmeli, Reyhan
Yalcin, Destina
Myoclonus-dystonia syndrome: case report
title Myoclonus-dystonia syndrome: case report
title_full Myoclonus-dystonia syndrome: case report
title_fullStr Myoclonus-dystonia syndrome: case report
title_full_unstemmed Myoclonus-dystonia syndrome: case report
title_short Myoclonus-dystonia syndrome: case report
title_sort myoclonus-dystonia syndrome: case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175042/
https://www.ncbi.nlm.nih.gov/pubmed/28058330
http://dx.doi.org/10.14744/nci.2014.28247
work_keys_str_mv AT akarsuemeloguz myoclonusdystoniasyndromecasereport
AT surmelireyhan myoclonusdystoniasyndromecasereport
AT yalcindestina myoclonusdystoniasyndromecasereport